Literature DB >> 8596234

Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials.

H C Bucher1, R J Cook, G H Guyatt, J D Lang, D J Cook, R Hatala, D L Hunt.   

Abstract

OBJECTIVE: To review the effect of supplemental calcium on blood pressure. DATA SOURCE: We searched MEDLINE and EMBASE for 1996 to May 1994. We contacted authors of eligible trials to ensure accuracy and completeness of data and to identify unpublished trials. STUDY SELECTION: We included any study in which investigators randomized people to calcium supplementation or placebo and measured blood pressure for at least 2 weeks. Fifty-six articles met the inclusion criteria, and 33 were eligible for analysis, involving a total of 2412 patients. DATA EXTRACTION: Two pairs of independent reviewers abstracted data and assessed validity according to six quality criteria. DATA SYNTHESIS: We calculated the differences in blood pressure change between the calcium supplementation group and the control group and pooled the estimates, with each trial weighted with the inverse of the variance using a random-effects model. Predictors of blood pressure reduction that we examined included method of supplementation, baseline blood pressure, and the methodological quality of the studies. The pooled analysis showed a reduction in systolic blood pressure of -1.27 mm Hg (95% confidence interval [CI], -2.25 to -0.29 mm Hg; P=.01) and in diastolic blood pressure of -0.24 mm Hg (95% CI, -0.92 to 0.44 mm Hg; P=.49). None of the possible mediators of blood pressure reduction explained differences in treatment effects.
CONCLUSIONS: Calcium supplementation may lead to a small reduction in systolic but not diastolic blood pressure. The results do not exclude a larger, important effect of calcium on blood pressure in subpopulations. In particular, further studies should address the hypothesis that inadequate calcium intake is associated with increased blood pressure that can be corrected with calcium supplementation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596234     DOI: 10.1001/jama.1996.03530370054031

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  51 in total

Review 1.  The DASH trials implicate dysfunction in calcium regulation in the pathogenesis of human hypertension.

Authors:  A G Logan
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 2.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  High consumptions of grain, fish, dairy products and combinations of these are associated with a low prevalence of metabolic syndrome.

Authors:  Jean-Bernard Ruidavets; Vanina Bongard; Jean Dallongeville; Dominique Arveiler; Pierre Ducimetière; Bertrand Perret; Chantal Simon; Philippe Amouyel; Jean Ferrières
Journal:  J Epidemiol Community Health       Date:  2007-09       Impact factor: 3.710

4.  Reporting of systematic reviews of micronutrients and health: a critical appraisal.

Authors:  Mei Chung; Ethan M Balk; Stanley Ip; Gowri Raman; Winifred W Yu; Thomas A Trikalinos; Alice H Lichtenstein; Elizabeth A Yetley; Joseph Lau
Journal:  Am J Clin Nutr       Date:  2009-02-25       Impact factor: 7.045

5.  Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study.

Authors:  Qian Xiao; Rachel A Murphy; Denise K Houston; Tamara B Harris; Wong-Ho Chow; Yikyung Park
Journal:  JAMA Intern Med       Date:  2013-04-22       Impact factor: 21.873

6.  A susceptibility haplotype within the endothelial nitric oxide synthase gene influences bone mineral density in hypertensive women.

Authors:  Monica Singh; Puneetpal Singh; Surinder Singh; Pawan Kumar Juneja; Taranpal Kaur
Journal:  J Bone Miner Metab       Date:  2013-11-10       Impact factor: 2.626

7.  Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men.

Authors:  Tianying Wu; Walter C Willett; Edward Giovannucci
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

8.  Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

Authors:  Karen L Margolis; Roberta M Ray; Linda Van Horn; Joann E Manson; Matthew A Allison; Henry R Black; Shirley A A Beresford; Stephanie A Connelly; J David Curb; Richard H Grimm; Theodore A Kotchen; Lewis H Kuller; Sylvia Wassertheil-Smoller; Cynthia A Thomson; James C Torner
Journal:  Hypertension       Date:  2008-09-29       Impact factor: 10.190

Review 9.  A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk.

Authors:  J Bruce German; Robert A Gibson; Ronald M Krauss; Paul Nestel; Benoît Lamarche; Wija A van Staveren; Jan M Steijns; Lisette C P G M de Groot; Adam L Lock; Frédéric Destaillats
Journal:  Eur J Nutr       Date:  2009-03-04       Impact factor: 5.614

10.  DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.

Authors:  Y Al-Solaiman; A Jesri; W K Mountford; D T Lackland; Y Zhao; B M Egan
Journal:  J Hum Hypertens       Date:  2009-07-23       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.